Minerva Neurosciences, Inc. (NERV)
| Previous Close | 2.5100 |
| Open | 2.5847 |
| Bid | 1.8000 x 200 |
| Ask | 3.2100 x 200 |
| Day's Range | 2.5000 - 2.5847 |
| 52 Week Range | 2.2860 - 13.4900 |
| Volume | |
| Avg. Volume | 107,440 |
| Market Cap | 17.553M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Minerva Neurosciences (NERV) Upgraded to Buy: What Does It Mean for the Stock?
Minerva Neurosciences (NERV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Insider Monkey
12 Best Performing Biotech Stocks in 2023
In this piece, we will take a look at the 12 best performing biotechnology stocks in 2023. If you want to skip our introduction to the biotechnology industry and some top players, then check out 5 Best Performing Biotech Stocks in 2023. Biotechnology is one of the hottest industries these days and one that has […]
- Zacks
Here's Why Minerva Neurosciences (NERV) Is a Great 'Buy the Bottom' Stock Now
Minerva Neurosciences (NERV) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
